Skip to main content
Caplight Logo









Climedo Health

Climedo Health

Private
MunichHealthcare & Life Scienceshttps://climedo.de/

Last Round

Seed

Feb 16, 2022

Total Funding Raised

$5.75M

Company Overview

Climedo Health is a healthtech company that provides a cloud-based, all-in-one digital platform for decentralized clinical trials, including electronic data capture (EDC) and electronic clinical outcome assessment (eCOA) solutions.

Sector

Healthcare & Life Sciences

Verticals

Clinical Trials, Medical Devices, Compliance, Patient Engagement

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

electronic data captureEDCclinical trial softwarepost-market surveillancePMSeCOAelectronic clinical outcome assessmenteConsentdecentralized clinical trialsDCTePROpatient engagement platformeClinicalregulatory compliance softwarevertical SaaSlife science software

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Climedo Health Comparables

Compare Climedo Health with similar companies based on industry and business-model similarity.

Climedo Health comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Eclevar Medtech
84%
ClinCapture, Inc.
83%
Curebase
79%

Climedo Health Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedFeb 16, 2022
GrantJun 2, 2020
SeedNov 25, 2019
GrantNov 13, 2017

Key People

Founding team and executive leadership

Dragan Mileski

Co-Founder & CTO

Founding Team

Sascha Ritz

Co-Founder & CEO

Founding Team

Climedo Health Investors

Notable investors and investment history

Climedo Health investors
InvestorRounds
EIT HealthGrant
WestTech VenturesSeed
Nauta CapitalSeed
Initiative for Industrial InnovatorsSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 19, 2026

    Monthly visitors grew 187% MoM, reaching 49.5K.

  • Feb 17, 2026

    Grew 17% QoQ, from 24 to 28 employees.

Climedo Health Filings

Explore SEC and related filing metadata, where available.

Climedo Health filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Climedo Health's valuation, stock price, and market status.

Is Climedo Health a public or private company?

Climedo Health is a private company.

What is the current stock price of Climedo Health?

Climedo Health is a private company with no public stock price. No recent secondary market data is available.

How much is Climedo Health worth (valuation)?

Valuation information for Climedo Health is not publicly available.

Can I buy Climedo Health stock?

Climedo Health shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Climedo Health's last funding round?

Climedo Health's most recent funding round was Seed on February 16, 2022.

Who are the main investors in Climedo Health?

Key investors in Climedo Health include Nauta Capital.

Will Climedo Health IPO soon?

No public IPO plans have been announced for Climedo Health.

How can I track Climedo Health secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Climedo Health's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersMunich
Employee Range20
Year Founded2017
Last FundingFeb 16, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?